Country Profile: Belgium
Children aged 2 to 12 months
All people aged 2 to 64 with asplenia or dysfunction of the spleen, chronic respiratory/heart/kidney/liver disease, diabetes, immunosuppression, cochlear implants and cerebrospinal fluid leaks
All people over the age of 65
Children: 93.80% (2021)
At-risk groups: –
Older adults: 10.60%* (2013)
Vaccination advisory body/committee
Belgian National Immunisation Technical Advisory Group
*Figure is an average of two age groups: 10.00% in people aged 65-84 years and 11.20% in people aged >85 years.
Belgian Health Care Knowledge Centre: https://kce.fgov.be/sites/default/files/2021-11/KCE_274C_Short-Report_Pneumococcal.pdf
Older adults aged 65 and over: vaccination is recommended but not funded by the National Health system.